Innate Pharma (IPHA) Pension (2017 - 2025)

Innate Pharma (IPHA) has 9 years of Pension data on file, last reported at $2.2 million in Q4 2025.

• For the quarter ending Q4 2025, Pension fell 23.27% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 23.27% YoY), and the FY2025 full-year result was $2.2 million, down 23.27% from the prior year.
• Pension for Q4 2025 stood at $2.2 million, down from $3.0 million in the prior quarter.
• Across five years, Pension topped out at $4.7 million in Q2 2021 and bottomed at $2.2 million in Q4 2025.
• The 5-year median for Pension is $2.8 million (2022), against an average of $3.0 million.
• The widest annual swing landed in 2021, when Pension slumped 99.89%; it then gained 13.46% in 2025.
• A 5-year view of Pension shows it stood at $3.4 million in 2021, then declined by 23.56% to $2.6 million in 2022, then increased by 0.95% to $2.6 million in 2023, then gained by 11.08% to $2.9 million in 2024, then fell by 23.27% to $2.2 million in 2025.
• The last three Pension figures came in at $2.2 million (Q4 2025), $3.0 million (Q2 2025), and $2.9 million (Q4 2024), per Business Quant data.

Peer Comparison